LD

Laurent David

HA H. Lundbeck A/S: 11 patents #58 of 451Top 15%
V( Vernalis (R&D): 2 patents #67 of 100Top 70%
Overall (All Time): #445,322 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12129289 Antibodies specific for hyperphosphorylated tau and methods of use thereof Jan Torleif Pedersen, Kristian Kjaergaard, Lars Østergaard Pedersen, Ayodeji Abdur-Rasheed Asuni, Nina Helen Rosenqvist +8 more 2024-10-29
11466027 Modulators of the NMDA receptor John Paul Kilburn, Erhad Ascic, Mauro Marigo 2022-10-11
11358971 Prodrugs of modulators of the NMDA receptor John Paul Kilburn, Erhad Ascic, Mauro Marigo 2022-06-14
11111290 Antibodies specific for hyperphosphorylated tau and methods of use thereof Jan Torleif Pedersen, Kristian Kjaergaard, Lars Østergaard Pedersen, Ayodeji Abdur-Rasheed Asuni, Nina Helen Rosenqvist +8 more 2021-09-07
10647762 Antibodies specific for hyperphosphorylated tau and methods of use thereof Jan Torleif Pedersen, Kristian Kjaergaard, Lars Østergaard Pedersen, Abdur-Rasheed Asuni, Nina Helen Rosenqvist +8 more 2020-05-12
10487142 Antibodies specific for hyperphosphorylated tau and methods of use thereof Jan Torleif Pedersen, Kristian Kjaergaard, Lars Østergaard Pedersen, Abdur-Rasheed Asuni, Nina Helen Rosenqvist +8 more 2019-11-26
10472415 Antibodies specific for hyperphosphorylated tau and methods of use Jan Torleif Pedersen, Kristian Kjærgaard, Lars Østergaard Pedersen, Abdur-Rasheed Asuni, Nina Helen Rosenqvist +8 more 2019-11-12
10195186 N-substituted-5-substituted phthalamic acids as sortilin inhibitors Philip James Maltas, Stephen Paul Watson, Morten Langgård 2019-02-05
9682967 N-substituted-5-substituted phthalamic acids as sortilin inhibitors Philip James Maltas, Stephen Paul Watson, Morten Langg{hacek over (a)}rd 2017-06-20
9393248 Aminopyridine derived compounds as LRRK2 inhibitors Gitte Kobberøe Mikkelsen, Stephen Paul Watson, Garrick Paul Smith, Douglas Stewart Williamson, I-Jen Chen 2016-07-19
9321748 Aminopyridine derived compounds as LRRK2 inhibitors Gitte Kobberøe Mikkelsen, Stephen Paul Watson, Garrick Paul Smith, Douglas Stewart Williamson, I-Jen Chen 2016-04-26